India, Sept. 12 -- Biocon hasannounced the inauguration of its first US manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics Inc (BGI).

The Governor of New Jersey, Phil Murphy, was the guest of honour at the inauguration. Biocon's Chairperson, Kiran Mazumdar-Shaw, and a distinguished gathering of dignitaries, customers, partners, and industry leaders were in attendance.

Biocon acquired the Oral Solid Dosage (OSD) facility from Eywa Pharma Inc. in 2023 and has since invested over $30 million to establish a state-of-the-art plant with an annual production capacity of 2 billion tablets.

A few products have already been commercialised from the site, with several more in the pipeline. This investme...